Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
Int J Environ Res Public Health. 2021 Dec 8;18(24):12952. doi: 10.3390/ijerph182412952.
Animal-assisted interventions (AAIs) are being implemented in many countries for the beneficial effects they have on humans. Patients involved in AAI are often individuals at greater risk of acquiring infections, and these activities involve close contact between humans and animals, as is the case with humans living with a pet. The spread of multidrug-resistant is a serious problem for human health; an integrated One Health strategy is imperative to combat this threat. Companion dogs can be a reservoir of multidrug-resistant pathogens, and animal-to-human transmission could occur during AAI sessions. The aim of this review was to collect the available data on the carriage of extended-spectrum beta-lactamase-producing and carbapenem-resistant in companion dogs and in an AAI context. Several papers have generally addressed the issue of microbial transmission during AAIs. Studies on the intestinal carriage of extended-spectrum beta-lactamase and/or carbapenem-resistant have mainly been conducted in companion animals while few data are available on the carriage in dogs participating in AAI sessions. This review aims to draw attention to the antibiotic resistance problem in a One Health context and to the importance of extending infection control measures to this human-animal interface, to keep the balance of benefits/risks for AAIs shifted towards the benefits of these activities.
动物辅助干预（AAI）正在许多国家实施，因为它们对人类有有益的影响。参与 AAI 的患者通常是感染风险较高的个体，这些活动涉及人类与动物的密切接触，就像与宠物一起生活的人类一样。多药耐药菌的传播对人类健康是一个严重的问题；必须采取综合的“同一健康”策略来应对这一威胁。伴侣犬可能是多药耐药病原体的储主，并且在 AAI 期间可能会发生动物到人类的传播。本综述的目的是收集有关伴侣犬和 AAI 环境中携带产超广谱β-内酰胺酶和碳青霉烯类耐药的的数据。许多论文通常都涉及到 AAI 期间微生物传播的问题。关于伴侣动物肠道携带产超广谱β-内酰胺酶和/或碳青霉烯类耐药的研究主要集中在伴侣动物上，而关于参与 AAI 会议的狗的携带情况的数据很少。本综述旨在提请人们注意同一健康背景下的抗生素耐药问题，并强调将感染控制措施扩展到这一人-动物界面的重要性，以保持 AAI 的利益/风险平衡向这些活动的利益倾斜。
